DFFVX
Price
$43.35
Change
+$0.02 (+0.05%)
Updated
Jul 13 closing price
Net Assets
16.37B
MLPIX
Price
$133.05
Change
-$0.06 (-0.05%)
Updated
Jul 13 closing price
Net Assets
2.09M
Interact to see
Advertisement

DFFVX vs MLPIX

DFFVX vs MLPIX Comparison Chart in %
View a ticker or compare two or three
VS
DFFVX vs. MLPIX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Buy and MLPIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 16.4B vs. MLPIX (2.09M). DFFVX pays higher dividends than MLPIX: DFFVX (1.51) vs MLPIX (0.42). DFFVX was incepted earlier than MLPIX: DFFVX (26 years) vs MLPIX (25 years). MLPIX (2.15) is less costly to investors than DFFVX (0.30). MLPIX is a more actively managed with annual turnover of: 988.00 vs. DFFVX (10.00). DFFVX has a lower initial minimum investment than MLPIX: DFFVX (0) vs MLPIX (15000). DFFVX annual gain was more profitable for investors over the last year : 26.97 vs. MLPIX (15.10). DFFVX return over 5 years is better than : 55.63 vs. MLPIX (41.08).
DFFVXMLPIXDFFVX / MLPIX
Total Expense Ratio0.291.7816%
Annual Report Gross Expense Ratio0.302.1514%
Fund Existence26 years25 years-
Gain YTD18.18011.129163%
Front LoadN/AN/A-
Min. Initial Investment015000-
Min. Initial Investment IRAN/AN/A-
Net Assets16.4B2.09M785,065%
Annual Yield % from dividends1.510.42359%
Returns for 1 year26.9715.10179%
Returns for 3 years55.0434.52159%
Returns for 5 years55.6341.08135%
Returns for 10 years118.5195.61124%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAGRX158.19N/A
N/A
Permanent Portfolio Aggressive Growth I
PNBAX30.86N/A
N/A
Virtus NFJ Large-Cap Value A
BDHCX9.06N/A
N/A
BlackRock Dynamic High Income Inv C
GQSCX19.16N/A
N/A
Glenmede Disciplined US Small Cap Eq Ptf
JFNNX88.26-0.68
-0.76%
Janus Henderson Global Life Sciences N